marketcaparena
Search

    AIM

    AIM ImmunoTech Inc.

    Company overview

    Market capitalization
    $5.61M
    Employees
    19
    Latest publication
    2026-09-29
    About AIM ImmunoTech Inc.

    AIM ImmunoTech Inc., an immuno-pharma company, engages in the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's flagship products are Ampligen (rintatolimod), a drug of large macromolecular double-stranded ribonucleic acid molecules to treat chronic fatigue syndrome; and Alferon N Injection (Interferon alfa), a purified, natural-source, glycosylated, multi-species alpha interferon product for the treatment of genital warts. It is also developing Ampligen for potential treatment of pancreatic, renal cell carcinoma, malignant melanoma, non-small cell lung, ovarian, breast, colorectal, and prostate cancers, as well as for myalgic encephalomyelitis, Hepatitis B, HIV, COVID-19, and post-COVID conditions. The company was formerly known as Hemispherx Biopharma, Inc. and changed its name to AIM ImmunoTech Inc. in August 2019. AIM ImmunoTech Inc. was founded in 1966 and is headquartered in Ocala, Florida.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Total Revenue22,000USD21,000USD26,000USD25,000USD16,000USD45,000USD35,000USD50,000USD
    Cost Of Revenue47,000USD40,000USD122,000USD10,000USD10,000USD-51,000USD8,000USD8,000USD
    Gross Profit-25,000USD-19,000USD-96,000USD15,000USD6,000USD96,000USD27,000USD42,000USD
    Research Development482,000USD1,063,000USD607,000USD1,174,000USD1,080,000USD1,664,000USD1,437,000USD1,145,000USD
    Selling General Administrative1,762,000USD1,870,000USD1,798,000USD1,487,000USD2,545,000USD4,229,000USD3,079,000USD2,591,000USD
    Total Operating Expenses2,201,000USD2,933,000USD2,269,000USD2,661,000USD3,625,000USD5,951,000USD4,516,000USD3,736,000USD
    Operating Income-2,226,000USD-2,952,000USD-2,365,000USD-2,646,000USD-3,619,000USD-5,855,000USD-4,489,000USD-3,694,000USD
    Interest Income8,000USD110,000USD3,052,000USD10,000USD11,000USD1,813,000USD718,000USD2,580,000USD
    Interest Expense304,000USD391,000USD148,000USD149,000USD124,000USD132,000USD202,000USD179,000USD
    Net Interest Income-296,000USD-281,000USD2,904,000USD-139,000USD-113,000USD1,681,000USD516,000USD2,401,000USD
    Income Before Tax-3,023,000USD-4,175,000USD-3,284,000USD-2,794,000USD-3,705,000USD-5,967,000USD-3,700,000USD-1,836,000USD
    Net Income-3,023,000USD-4,175,000USD-3,284,000USD-2,794,000USD-3,705,000USD-5,967,000USD-3,700,000USD-1,836,000USD
    Net Income From Continuing Ops-3,023,000USD-4,175,000USD-3,284,000USD-2,794,000USD-3,705,000USD-5,967,000USD-3,700,000USD-1,836,000USD
    Ebit-2,226,000USD-3,784,000USD-3,136,000USD-2,645,000USD-3,581,000USD-5,835,000USD-3,498,000USD-1,657,000USD
    Ebitda-2,183,000USD-3,741,000USD-3,082,000USD-2,590,000USD-3,459,000USD-5,771,000USD-3,435,000USD-1,596,000USD
    Depreciation And Amortization43,000USD43,000USD54,000USD55,000USD122,000USD64,000USD63,000USD61,000USD
    Reconciled Depreciation43,000USD43,000USD54,000USD55,000USD58,000USD64,000USD63,000USD61,000USD
    Total Other Income Expense Net-797,000USD-1,223,000USD-919,000USD-148,000USD-86,000USD-112,000USD789,000USD1,858,000USD
    Net Income Applicable To Common Shares—-4,175,000USD-3,284,000USD-2,794,000USD-3,705,000USD-5,967,000USD-3,700,000USD—
    Selling And Marketing Expenses—————58,000USD—61,000USD
    Income Tax Expense—————-14,724USD-3,700,000USD—
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Revenue88,000USD170,000USD202,000USD141,000USD135,000USD163,000USD140,000USD367,000USD
    Cost Of Revenue338,000USD31,000USD42,000USD-424,000USD850,000USD806,000USD893,000USD884,000USD
    Gross Profit-250,000USD139,000USD160,000USD141,000USD-715,000USD-643,000USD-753,000USD-517,000USD
    Research Development3,924,000USD6,197,000USD10,925,000USD6,990,000USD7,672,000USD5,720,000USD4,651,000USD4,778,000USD
    Selling General Administrative7,700,000USD13,714,000USD21,137,000USD13,074,000USD8,672,000USD8,654,000USD7,039,000USD6,201,000USD
    Unclassified Operating Expenses-1,348,000USD———1,779,000USD———
    Total Operating Expenses10,276,000USD19,911,000USD32,076,000USD20,064,000USD18,123,000USD14,509,000USD11,690,000USD10,979,000USD
    Operating Income-10,526,000USD-19,772,000USD-31,916,000USD-19,922,810USD-18,838,000USD-15,152,000USD-12,443,000USD-11,496,000USD
    Interest Income3,183,000USD5,192,000USD1,069,000USD629,000USD0USD219,000USD89,000USD—
    Interest Expense812,000USD585,000USD0USD478,000USD67,000USD672,000USD427,000USD502,000USD
    Net Interest Income2,371,000USD4,607,000USD1,069,000USD629,000USD-67,000USD-672,000USD-338,000USD—
    Income Before Tax-13,958,000USD-17,320,000USD-28,962,000USD-19,445,000USD-19,127,000USD-14,400,000USD-9,404,000USD-9,813,000USD
    Net Income-13,958,000USD-17,320,000USD-28,962,000USD-19,445,000USD-19,127,000USD-14,400,000USD-9,404,000USD-9,813,000USD
    Net Income From Continuing Ops-13,958,000USD-17,320,000USD-28,962,000USD-19,445,000USD-19,127,000USD-14,400,000USD-9,404,000USD—
    Ebit-10,526,000USD-16,735,000USD-28,962,000USD-19,445,000USD-19,060,000USD-13,728,000USD-8,977,000USD-9,325,000USD
    Ebitda-10,316,000USD-16,489,000USD-28,724,000USD-19,869,000USD-18,285,000USD-12,995,000USD-8,148,000USD-8,405,000USD
    Depreciation And Amortization210,000USD246,000USD238,000USD-424,000USD775,000USD733,000USD829,000USD920,000USD
    Reconciled Depreciation210,000USD246,000USD238,000USD256,000USD775,000USD733,000USD792,000USD—
    Total Other Income Expense Net-3,432,000USD2,452,000USD2,954,000USD477,810USD-289,000USD752,000USD3,039,000USD1,669,000USD
    Net Income Applicable To Common Shares-13,958,000USD-17,320,000USD-28,962,000USD-19,445,000USD————
    Selling And Marketing Expenses——623,000USD339,000USD————
    Income Tax Expense———1,641,000USD2,386,000USD1,858,000USD1,293,000USD2,185,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Total Assets8,585,000USD5,782,000USD5,494,000USD4,129,000USD6,248,000USD8,608,000USD13,588,000USD15,715,000USD
    Intangible Assets1,662,000USD1,661,000USD2,041,000USD2,168,000USD2,267,000USD2,594,000USD2,532,000USD2,491,000USD
    Other Current Assets335,000USD2,295,000USD166,000USD190,000USD318,000USD199,000USD368,000USD300,000USD
    Total Liab6,460,000USD15,565,000USD11,571,000USD10,675,000USD10,105,000USD9,930,000USD10,676,000USD9,613,000USD
    Total Stockholder Equity2,125,000USD-9,783,000USD-6,077,000USD-6,546,000USD-3,857,000USD-1,322,000USD2,912,000USD6,102,000USD
    Other Current Liab671,000USD795,000USD679,000USD573,000USD639,000USD606,000USD1,010,000USD799,000USD
    Common Stock8,000USD3,000USD3,000USD1,000USD72,000USD66,000USD59,000USD57,000USD
    Capital Stock8,000USD3,000USD3,000USD1,000USD72,000USD66,000USD59,000USD57,000USD
    Retained Earnings-443,809,000USD-440,786,000USD-436,611,000USD-433,327,000USD-430,533,000USD-426,828,000USD-420,861,000USD-417,161,000USD
    Cash5,816,000USD931,000USD2,347,000USD476,000USD898,000USD1,701,000USD915,000USD3,554,000USD
    Cash And Short Term Investments5,879,000USD993,000USD2,409,000USD835,000USD2,247,000USD3,977,000USD7,202,000USD10,061,000USD
    Total Current Assets6,214,000USD3,295,000USD2,575,000USD1,025,000USD2,584,000USD4,176,000USD7,570,000USD10,361,000USD
    Total Current Liabilities6,145,000USD6,224,000USD4,043,000USD10,393,000USD9,767,000USD9,535,000USD10,100,000USD8,842,000USD
    Net Debt-1,242,000USD3,965,000USD-9,000USD2,329,000USD1,624,000USD1,240,000USD2,486,000USD-195,000USD
    Short Term Debt4,259,000USD3,799,000USD2,112,000USD2,523,000USD2,184,000USD2,546,000USD2,825,000USD2,588,000USD
    Short Long Term Debt4,004,000USD3,549,000USD1,880,000USD2,290,000USD1,950,000USD2,307,000USD2,593,000USD2,354,000USD
    Short Long Term Debt Total4,574,000USD4,896,000USD2,338,000USD2,805,000USD2,522,000USD2,941,000USD3,401,000USD3,359,000USD
    Long Term Debt210,000USD927,000USD————139,000USD283,000USD
    Short Term Investments63,000USD62,000USD62,000USD359,000USD1,349,000USD2,276,000USD6,287,000USD6,507,000USD
    Accounts Payable1,215,000USD1,630,000USD1,252,000USD7,297,000USD6,944,000USD6,383,000USD6,264,000USD5,455,000USD
    Property Plant Equipment Net382,000USD449,000USD516,000USD585,000USD652,000USD726,000USD770,000USD809,000USD
    Property Plant Equipment Gross2,404,000USD1,844,000USD1,902,000USD1,962,000USD2,020,000USD2,084,000USD2,119,000USD2,148,000USD
    Common Stock Shares Outstanding4,351,449shares3,072,944shares2,093,446shares2,093,360shares1,938,993shares1,567,269shares1,590,155shares1,456,727shares
    Non Current Assets Total2,371,000USD2,487,000USD2,918,999USD3,104,000USD3,664,000USD4,432,000USD6,018,000USD5,354,000USD
    Non Current Liabilities Total315,000USD9,341,000USD7,528,000USD282,000USD338,000USD395,000USD576,000USD771,000USD
    Non Currrent Assets Other327,000USD826,000USD361,999USD351,000USD745,000USD1,112,000USD2,716,000USD2,054,000USD
    Net Working Capital69,000USD-2,929,000USD-1,468,000USD-9,368,000USD-7,183,000USD-5,359,000USD-2,530,000USD1,519,000USD
    Unclassified Current Liabilities-4,004,000USD-3,549,000USD-1,880,000USD-2,290,000USD-1,950,000USD-2,307,000USD-2,592,999USD-2,354,000USD
    Unclassified Equity445,918,000USD430,997,000USD430,528,000USD426,779,000USD426,532,000USD425,374,000USD423,655,000USD423,149,000USD
    Other Assets—377,000USD362,000USD351,000USD745,000USD1,112,000USD2,716,000USD1USD
    Cash And Equivalents—2,985,000USD2,347,000USD476,000USD898,000USD1,701,000USD915,000USD—
    Net Receivables—7,000USD——19,000USD—0USD0USD
    Unclassified Non Current Liabilities—8,414,000USD7,528,000USD—————
    Unclassified Non Current Assets—————-1,112,000USD-2,716,000USD—
    Current Deferred Revenue——————999USD—
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets5,782,000USD8,608,000USD19,381,000USD40,488,000USD57,699,000USD111,021,000USD20,219,000USD13,845,000USD
    Intangible Assets1,661,000USD2,594,000USD2,313,000USD1,941,000USD1,974,000USD1,498,000USD1,151,000USD912,000USD
    Other Current Assets2,295,000USD199,000USD604,000USD455,000USD304,000USD184,000USD848,000USD880,000USD
    Total Liab15,565,000USD9,930,000USD9,147,000USD2,020,000USD820,000USD49,727,000USD7,312,000USD8,671,000USD
    Total Stockholder Equity-9,783,000USD-1,322,000USD10,234,000USD38,468,000USD56,879,000USD61,294,000USD12,907,000USD5,174,000USD
    Other Current Liab795,000USD606,000USD1,986,000USD806,000USD438,000USD442,000USD403,000USD1,005,000USD
    Common Stock3,000USD66,000USD49,000USD48,000USD48,000USD42,000USD10,000USD1,000USD
    Capital Stock3,000USD66,000USD738,000USD744,000USD763,000USD774,000USD788,000USD—
    Retained Earnings-440,786,000USD-426,828,000USD-409,508,000USD-380,546,000USD-361,101,000USD-341,974,000USD-328,109,000USD-318,573,000USD
    Other Assets377,000USD-4,432,000USD1USD1,202,000USD————
    Cash931,000USD1,701,000USD5,439,000USD27,053,000USD32,093,000USD38,501,000USD1,470,000USD299,000USD
    Cash And Equivalents2,985,000USD1,701,000USD5,439,000USD27,053,000USD————
    Cash And Short Term Investments993,000USD3,977,000USD13,070,000USD34,190,000USD48,268,000USD39,002,000USD8,778,000USD1,825,000USD
    Total Current Assets3,295,000USD4,176,000USD14,556,000USD36,321,000USD50,213,000USD40,310,000USD10,446,000USD3,799,000USD
    Total Current Liabilities6,224,000USD9,535,000USD8,652,000USD1,361,000USD673,000USD1,102,000USD1,127,000USD5,292,000USD
    Net Debt3,965,000USD1,240,000USD-4,721,000USD-26,216,000USD-31,944,000USD-36,216,000USD4,910,000USD5,626,000USD
    Short Term Debt3,799,000USD2,546,000USD223,000USD178,000USD37,000USD277,000USD252,000USD3,607,000USD
    Short Long Term Debt3,549,000USD2,307,000USD———230,000USD214,000USD—
    Short Long Term Debt Total4,896,000USD2,941,000USD718,000USD837,000USD149,000USD2,285,000USD6,380,000USD5,925,000USD
    Long Term Debt927,000USD—————3,910,000USD—
    Short Term Investments62,000USD2,276,000USD7,631,000USD7,137,000USD16,175,000USD501,000USD7,308,000USD1,526,000USD
    Net Receivables7,000USD—1,184,000USD1,676,000USD1,641,000USD1,124,000USD820,000USD1,094,000USD
    Accounts Payable1,630,000USD6,383,000USD6,443,000USD377,000USD198,000USD383,000USD472,000USD680,000USD
    Property Plant Equipment Net449,000USD726,000USD824,000USD1,024,000USD4,196,000USD6,652,000USD7,268,000USD7,782,000USD
    Property Plant Equipment Gross1,844,000USD2,084,000USD2,145,000USD3,062,000USD6,402,000USD15,862,000USD15,813,000USD—
    Common Stock Shares Outstanding1,618,617shares1,544,383shares1,339,499shares1,324,661shares1,305,161shares877,903shares100,429shares27,689shares
    Non Current Assets Total2,487,000USD4,432,000USD4,825,000USD4,167,000USD7,486,000USD70,711,000USD9,773,000USD10,046,000USD
    Non Current Liabilities Total9,341,000USD395,000USD495,000USD659,000USD147,000USD48,625,000USD6,185,000USD3,379,000USD
    Non Currrent Assets Other826,000USD1,112,000USD1,688,000USD1,202,000USD1,316,000USD116,000USD1,354,000USD1,352,000USD
    Net Working Capital-2,929,000USD-5,359,000USD5,904,000USD34,960,000USD49,540,000USD39,208,000USD9,319,000USD—
    Unclassified Current Liabilities-3,549,000USD-2,307,000USD——————
    Unclassified Non Current Liabilities8,414,000USD————46,749,000USD—3,379,000USD
    Unclassified Equity430,997,000USD425,374,000USD418,955,000USD418,222,000USD417,169,000USD402,499,000USD348,763,000USD323,749,000USD
    Current Deferred Revenue——-223,000USD——212,000USD189,000USD806,000USD
    Inventory——-302,000USD———1USD1USD
    Accumulated Other Comprehensive Income——0USD——-47,000USD-8,545,000USD-3,000USD
    Unclassified Non Current Assets———-1,202,000USD—47,069,000USD——
    Long Term Investments————0USD15,376,000USD0USD—
    Non Current Liabilities Other—————1,876,000USD2,104,000USD—
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income-3,023,000USD-4,175,000USD-3,284,000USD-2,794,000USD-3,705,000USD-5,967,000USD-3,700,000USD-1,836,000USD
    Depreciation43,000USD43,000USD54,000USD55,000USD58,000USD64,000USD63,000USD61,000USD
    Stock Based Compensation0USD0USD0USD0USD60,000USD196,000USD330,000USD80,000USD
    Other Non Cash Items-2,228,000USD2,271,000USD477,000USD425,000USD436,000USD337,000USD-188,000USD957,000USD
    Change To Account Receivables7,000USD-7,000USD—19,000USD-19,000USD3,000USD—-3,000USD
    Change In Working Capital-491,000USD-125,000USD-2,326,000USD783,000USD790,000USD1,415,000USD385,000USD-2,270,000USD
    Total Cash From Operating Activities-2,719,000USD-1,986,000USD-5,079,000USD-1,531,000USD-2,361,000USD-3,955,000USD-3,110,000USD-3,008,000USD
    Capital Expenditures-35,000USD-95,000USD-283,000USD-227,000USD-56,000USD-119,000USD-158,000USD-229,000USD
    Free Cash Flow-2,754,000USD-1,986,000USD-5,079,000USD-1,758,000USD-2,417,000USD-4,074,000USD-3,268,000USD-3,237,000USD
    Investments-2,000USD0USD296,000USD754,000USD898,000USD3,704,000USD334,000USD826,000USD
    Total Cashflows From Investing Activities-37,000USD-95,000USD296,000USD754,000USD898,000USD3,704,000USD334,000USD826,000USD
    Net Borrowings-200,000USD2,500,000USD-660,000USD250,000USD0USD-251,000USD133,000USD—
    Total Cash From Financing Activities5,587,000USD2,719,000USD6,654,000USD355,000USD660,000USD1,037,000USD137,000USD2,441,000USD
    Issuance Of Capital Stock3,631,000USD617,000USD6,916,000USD105,000USD660,000USD32,000USD4,000USD527,000USD
    Change In Cash2,831,000USD638,000USD1,871,000USD-422,000USD-803,000USD786,000USD-2,639,000USD259,000USD
    Begin Period Cash Flow2,985,000USD2,347,000USD476,000USD898,000USD1,701,000USD915,000USD3,554,000USD3,295,000USD
    End Period Cash Flow5,816,000USD2,985,000USD2,347,000USD476,000USD898,000USD1,701,000USD915,000USD3,554,000USD
    Other Cashflows From Investing Activities-37,000USD2,231,000USD2,231,000USD1,935,000USD954,000USD-402,000USD1,020,000USD-229,000USD
    Other Cashflows From Financing Activities1,630,000USD————3,303,000USD334,000USD2,047,000USD
    Unclassified Operating Cash Flow2,980,000USD———————
    Sale Purchase Of Stock—8,298,000USD8,079,000USD765,000USD660,000USD4,195,000USD2,907,000USD—
    Unclassified Investing Cash Flow—-2,231,000USD-1,948,000USD-1,708,000USD————
    Unclassified Financing Cash Flow—-8,079,000USD———-6,210,000USD-3,237,000USD—
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income-13,958,000USD-17,320,000USD-28,962,000USD-19,445,000USD-19,127,000USD-14,400,000USD-9,533,000USD-9,813,000USD
    Depreciation37,000USD246,000USD238,000USD256,000USD805,000USD733,000USD792,000USD878,000USD
    Stock Based Compensation60,000USD686,000USD243,000USD954,000USD1,568,000USD1,036,000USD853,000USD929,000USD
    Other Non Cash Items3,782,000USD1,204,000USD310,000USD964,000USD4,213,000USD1,754,000USD255,000USD845,000USD
    Change To Account Receivables-7,000USD1,184,000USD492,000USD-35,000USD34,000USD40,000USD274,000USD-1,070,000USD
    Change In Working Capital-878,000USD296,000USD1,065,000USD966,000USD895,000USD605,000USD-543,000USD-2,077,000USD
    Total Cash From Operating Activities-10,957,000USD-14,888,000USD-21,267,000USD-16,108,000USD-13,965,000USD-10,368,000USD-9,067,000USD-10,640,000USD
    Capital Expenditures-378,000USD-18,000USD-585,000USD-271,000USD-633,000USD-595,000USD-365,000USD-127,000USD
    Free Cash Flow-10,957,000USD-14,906,000USD-21,852,000USD-16,379,000USD-14,598,000USD-10,963,000USD-9,432,000USD-10,767,000USD
    Investments2,231,000USD4,706,000USD-832,000USD10,988,000USD-631,000USD-9,164,000USD-6,147,000USD—
    Total Cashflows From Investing Activities1,853,000USD4,706,000USD-832,000USD10,988,000USD-631,000USD-9,164,000USD-6,147,000USD92,000USD
    Net Borrowings2,090,000USD2,249,000USD0USD0USD-4,854,000USD———
    Total Cash From Financing Activities10,388,000USD6,444,000USD485,000USD80,000USD8,188,000USD56,563,000USD16,385,000USD9,435,000USD
    Sale Purchase Of Stock8,298,000USD4,195,000USD485,000USD80,000USD————
    Issuance Of Capital Stock8,298,000USD892,000USD485,000USD80,000USD13,042,000USD61,248,000USD15,303,000USD—
    Change In Cash1,284,000USD-3,738,000USD-21,614,000USD-5,040,000USD-6,408,000USD37,031,000USD1,171,000USD-1,113,000USD
    Begin Period Cash Flow1,701,000USD5,439,000USD27,053,000USD32,093,000USD38,501,000USD1,470,000USD299,000USD1,412,000USD
    End Period Cash Flow2,985,000USD1,701,000USD5,439,000USD27,053,000USD32,093,000USD38,501,000USD1,470,000USD299,000USD
    Other Cashflows From Investing Activities17,000USD-631,000USD-585,000USD11,074,000USD-347,000USD-573,000USD-6,079,000USD1,126,000USD
    Other Cashflows From Financing Activities10,388,000USD3,303,000USD485,000USD10,988,000USD13,042,000USD61,248,000USD3,632,000USD-553,000USD
    Unclassified Financing Cash Flow-10,388,000USD-3,303,000USD—-10,988,000USD-13,042,000USD-65,933,000USD-2,550,000USD9,988,000USD
    Unclassified Operating Cash Flow——5,839,000USD—-2,319,000USD——-1,402,000USD
    Unclassified Investing Cash Flow——1,170,000USD-10,803,000USD—1,168,000USD6,444,000USD—
    Change To Inventory———35,000USD——-647,000USD—
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    FY 2020Yearly · 2020-12-31GeographyEurope19,000USD0001493152-21-007259
    FY 2020Yearly · 2020-12-31GeographyUnited States144,000USD0001493152-21-007259
    FY 2020Yearly · 2020-12-31ProductClinical Treatment Programs Europe19,000USD0001493152-22-008324
    FY 2020Yearly · 2020-12-31ProductClinical Treatment Programs US144,000USD0001493152-22-008324
    Q3 2020Quarterly · 2020-09-30ProductClinical Treatment Programs Europe9,000USD0001493152-21-028650
    Q3 2020Quarterly · 2020-09-30ProductClinical Treatment Programs US27,000USD0001493152-21-028650
    Q1 2020Quarterly · 2020-03-31GeographyEurope2,000USD0001493152-21-011883
    Q1 2020Quarterly · 2020-03-31GeographyUnited States43,000USD0001493152-21-011883
    FY 2019Yearly · 2019-12-31GeographyEurope30,000USD0001493152-21-007259
    FY 2019Yearly · 2019-12-31GeographyUnited States110,000USD0001493152-21-007259

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.